Insight into mucinous colorectal carcinoma: Clues from etiology

Annals of Surgical Oncology

Volumn 21, Issue 9, 2014, Pages 2963-2970

  Hugen, Niek ^a   Van Beek, Jasper J P ^a   De Wilt, Johannes H W ^a   Nagtegaal, Iris D ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL OBSERVATION; COLLOID CARCINOMA; COLORECTAL CARCINOMA; GEOGRAPHICAL VARIATION (SPECIES); HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INFLAMMATORY BOWEL DISEASE; NONHUMAN; PREVALENCE; REVIEW; ADENOCARCINOMA, MUCINOUS; COLORECTAL TUMOR; COMPLICATION; PATHOLOGY; PROGNOSIS; RISK FACTOR;

ADENOCARCINOMA, MUCINOUS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 84906251530     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3706-6     Document Type: Review

References (117)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.
2. Hyngstrom JR, Hu CY, Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012;19(9):2814-21.
3. Hugen N, Verhoeven RH, Radema SA, et al. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Ann Oncol. 2013;24(11):2819-24.
4. Hugen N, van de Velde CJ, de Wilt JH, et al. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014;25(3):651-7.
5. Mekenkamp LJ, Heesterbeek KJ, Koopman M, et al. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer. 2012;48(4):501-9.
6. Negri FV, Wotherspoon A, Cunningham D, et al. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol. 2005;16(8):1305-10. (Pubitemid 41158475)
7. Catalano V, Loupakis F, Graziano F, et al. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer. 2009;100(6):881-7.
8. Bosman FT. World Health Organization. International Agency for Research on Cancer. WHO classification of tumours of the digestive system. 4th edn. Lyon: International Agency for Research on Cancer, 2010.
9. Song GA, Deng G, Bell I, et al. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. Int J Oncol. 2005;26(3):745-50.
10. Hanski C. Is mucinous carcinoma of the colorectum a distinct genetic entity? Br J Cancer. 1995;72(6):1350-6. (Pubitemid 26002642)
11. Du W, Mah JT, Lee J, et al. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum. 2004;47(1):78-85. (Pubitemid 38040249)
12. Sasaki S, Masaki T, Umetani N, et al. Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observations. Jpn J Clin Oncol. 1998;28(3):202-6. (Pubitemid 128525570)
13. Kanemitsu Y, Kato T, Hirai T, et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum. 2003;46(2):160-7. (Pubitemid 36222614)
14. Yamaguchi T, Taniguchi H, Fujita S, et al. Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma. Histopathology. 2012;61(2):162-9.
15. Numata M, Shiozawa M, Watanabe T, et al. The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World J Surg Oncol. 2012;10:109.
16. Lee WS, Chun HK, Lee WY, et al. Treatment outcomes in patients with signet ring cell carcinoma of the colorectum. Am J Surg. 2007;194(3):294-8. (Pubitemid 47212047)
17. You JF, Hsieh LL, Changchien CR, et al. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients. Clin Cancer Res. 2006;12(14 Pt 1):4244-50.
18. Song W, Wu SJ, He YL, et al. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl). 2009;122(13):1486-91.
19. Gao P, Song YX, Xu YY, et al. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases. Histopathology. 2013;63(5):603-15.
20. Kaw LL Jr, Punzalan CK, Crisostomo AC, et al. Surgical pathology of colorectal cancer in Filipinos: implications for clinical practice. J Am Coll Surg. 2002;195(2):188-95. (Pubitemid 34832678)
21. Thomas RM, Sobin LH. Gastrointestinal cancer. Cancer. 1995;75(1 Suppl):154-70.
22. Kang H, O'Connell JB, Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005;48(6):1161-8. (Pubitemid 40897859)
23. Xie L, Villeneuve PJ, Shaw A. Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int J Oncol. 2009;34(4):1109-15.
24. Morikawa T, Kuchiba A, Qian ZR, et al. Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol. 2012;19(6):1944-53.
25. Engeland A, Tretli S, Austad G, et al. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control. 2005;16(8):987-96. (Pubitemid 41191423)
26. Erichsen R, Baron JA, Stoffel EM, et al. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol. 2013;108(8):1332-40.
27. Nitsche U, Zimmermann A, Spath C, et al. Mucinous and signetring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg. 2013;258(5):775-83.
28. Papadopoulos VN, Michalopoulos A, Netta S, et al. Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol. 2004;8(Suppl 1):s123-5. (Pubitemid 40394533)
29. Benatti P, Gafa R, Barana D, et al. Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res. 2005;11(23):8332-40. (Pubitemid 41746945)
30. Safaee A, Moghimi-Dehkordi B, Fatemi SR, et al. Characteristics of colorectal mucinous adenocarcinoma in Iran. Asian Pac J Cancer Prev. 2010;11(5):1373-5.
31. Veruttipong D, Soliman AS, Gilbert SF, et al. Age distribution, polyps and rectal cancer in the Egyptian population-based cancer registry. World J Gastroenterol. 2012;18(30):3997-4003.
32. Day FL, Jorissen RN, Lipton L, et al. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer. Clin Cancer Res. 2013;19(12):3285-96.
33. Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133-45.
34. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526-35. (Pubitemid 32234798)
35. Lutgens MW, van Oijen MG, van der Heijden GJ, et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19(4):789-99.
36. Gyde SN, Prior P, Macartney JC, et al. Malignancy in Crohn's disease. Gut. 1980;21(12):1024-9. (Pubitemid 11184245)
37. Savoca PE, Ballantyne GH, Cahow CE. Gastrointestinal malignancies in Crohn's disease. A 20-year experience. Dis Colon Rectum. 1990;33(1):7-11. (Pubitemid 20054299)
38. Sugita A, Greenstein AJ, Ribeiro MB, et al. Survival with colorectal cancer in ulcerative colitis. A study of 102 cases. Ann Surg. 1993;218(2):189-95. (Pubitemid 23229146)
39. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35(7):950-4.
40. Connell WR, Talbot IC, Harpaz N, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994;35(10):1419-23. (Pubitemid 24310904)
41. Rubio CA, Befrits R. Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study. Dis Colon Rectum. 1997;40(9):1072-8. (Pubitemid 27377586)
42. Mayer R, Wong WD, Rothenberger DA, et al. Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum. 1999;42(3):343-7. (Pubitemid 29143833)
43. Svrcek M, Cosnes J, Beaugerie L, et al. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Histopathology. 2007;50(5):574-83. (Pubitemid 46495833)
44. Brackmann S, Andersen SN, Aamodt G, et al. Two distinct groups of colorectal cancer in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(1):9-16.
45. Higashi D, Futami K, Ishibashi Y, et al. Clinical course of colorectal cancer in patients with ulcerative colitis. Anticancer Res. 2011;31(7):2499-504.
46. Watanabe T, Konishi T, Kishimoto J, et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17(3):802-8.
47. Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 2000;60(13):3333-7. (Pubitemid 30482141)
48. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-99.
49. Gasche C, Chang CL, Rhees J, et al. Oxidative stress increases frameshift mutations in human colorectal cancer cells. Cancer Res. 2001;61(20):7444-8. (Pubitemid 32995032)
50. Aust DE, Terdiman JP, Willenbucher RF, et al. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer. 2002;94(5):1421-7. (Pubitemid 34212635)
51. Sanchez JA, Dejulius KL, Bronner M, et al. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011;17(9):1966-70.
52. Brentnall TA, Crispin DA, Rabinovitch PS, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology. 1994;107(2):369-78. (Pubitemid 24233310)
53. Zhang H, Evertsson S, Sun X. Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum. Int J Oncol. 1999;14(6):1057-61.
54. King-Yin Lam A, Ong K, Ho YH. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum. 2006;49(9):1275-83. (Pubitemid 44401375)
55. Hanski C, Bornhoeft G, Shimoda T, et al. Expression of p53 protein in invasive colorectal carcinomas of different histologic types. Cancer. 1992;70(12):2772-7.
56. Brentnall TA, Crispin DA, Bronner MP, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 1996;56(6):1237-40. (Pubitemid 26080961)
57. Edwards RA, Witherspoon M, Wang K, et al. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Cancer Res. 2009;69(16):6423-9.
58. Chang CL, Marra G, Chauhan DP, et al. Oxidative stress inactivates the human DNA mismatch repair system. Am J Physiol Cell Physiol. 2002;283(1):C148-54. (Pubitemid 34670558)
59. Iwashita J, Sato Y, Sugaya H, et al. mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol. 2003;81(4):275-82. (Pubitemid 36904334)
60. Okudaira K, Kakar S, Cun L, et al. MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues. Int J Oncol. 2010;36(4):765-75.
61. Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62(4):630-49.
62. Kountouras J, Zavos C. Recent advances in the management of radiation colitis. World J Gastroenterol. 2008;14(48):7289-301.
63. Slaughter DP, Southwick HW. Mucosal carcinomas as a result of irradiation. AMA Arch Surg. 1957;74(3):420-9.
64. Smith J. Carcinoma of the rectum following irradiation of carcinoma of the cervix. Proc R Soc Med. 1962;55:701-2.
65. Black WC 3rd, Ackerman LV. Carcinoma of the large intestine as a late complication of pelvic radiotherapy. Clin Radiol. 1965;16:278-81.
66. Pemberton M, Lendrum J. Squamous-cell carcinoma of the caecum following ovarian adenocarcinoma. Br J Surg. 1968;55(4):273-6.
67. DeCosse JJ, Rhodes RS, Wentz WB, et al. The natural history and management of radiation induced injury of the gastrointestinal tract. Ann Surg. 1969;170(3):369-84.
68. Localio SA, Stone A, Friedman M. Surgical aspects of radiation enteritis. Surg Gynecol Obstet. 1969;129(6):1163-72.
69. MacMahon CE, Rowe JW. Rectal reaction following radiation therapy of cervical carcinoma: particular reference to subsequent occurrence of rectal carcinoma. Ann Surg. 1971;173(2):264-9.
70. Castro EB, Rosen PP, Quan SH. Carcinoma of large intestine in patients irradiated for carcinoma of cervix and uterus. Cancer. 1973;31(1):45-52.
71. Cunningham MP, Wilhoite R. Radiation-induced carcinoma of the transverse colon: report of a case. Dis Colon Rectum. 1973;16(2):145-8.
72. Qizilbash AH. Radiation-induced carcinoma of the rectum. A late complication of pelvic irradiation. Arch Pathol. 1974;98(2):118-21.
73. Burri B, Mosimann R. A propos de quatre tumeurs malignes colo-rectales et du péritoine apparues après irradiation pelvienne. Helv Chir Acta. 1978;45:101-4. (Pubitemid 8349908)
74. Greenwald R, Barkin JS, Hensley GT, et al. Cancer of the colon as a late sequel of pelvic irradiation. Am J Gastroenterol. 1978;69(2):196-8. (Pubitemid 8359668)
75. O'Connor TW, Rombeau JL, Levine HS, et al. Late development of colorectal cancer subsequent to pelvic irradiation. Dis Colon Rectum. 1979;22(2):123-8. (Pubitemid 9149881)
76. Sabio H, Teja K, Elkon D, et al. Adenocarcinoma of the colon following the treatment of Wilms tumor. J Pediatr. 1979;95(3):424-6. (Pubitemid 9220171)
77. Martins A, Sternberg SS, Attiyeh FF. Radiation-induced carcinoma of the rectum. Dis Colon Rectum. 1980;23(8):572-5. (Pubitemid 11190994)
78. Tan BC, Chia KB. Radiation induced cancer: a report of ten cases. Ann Acad Med Singapore. 1981;10(3):267-76.
79. Jao SW, Beart RW Jr, Reiman HM, et al. Colon and anorectal cancer after pelvic irradiation. Dis Colon Rectum. 1987;30(12):953-8. (Pubitemid 18018811)
80. Hareyama M, Okubo O, Oouchi A, et al. A case of carcinoma of the rectum after radiotherapy for carcinoma of the cervix. Radiat Med. 1989;7(4):197-200. (Pubitemid 20078517)
81. Levitt MD, Millar DM, Stewart JO. Rectal cancer after pelvic irradiation. J R Soc Med. 1990;83(3):152-4. (Pubitemid 20152238)
82. Shirouzu K, Isomoto H, Morodomi T, et al. Clinicopathologic characteristics of large bowel cancer developing after radiotherapy for uterine cervical cancer. Dis Colon Rectum. 1994;37(12):1245-9.
83. Kimura T, Iwagaki H, Hizuta A, et al. Colorectal cancer after irradiation for cervical cancer-case reports. Anticancer Res. 1995;15(2):557-8.
84. Morita H, Koyama N, Tamura Y. Development of flat adenoma and superficial rectal cancer after pelvic radiation. J Clin Gastroenterol. 1998;26(3):171-4. (Pubitemid 28211358)
85. Minami K, Matsuzaki S, Hayashi N, et al. Immunohistochemical study of p53 overexpression in radiation-induced colon cancers. J Radiat Res. 1998;39(1):1-10. (Pubitemid 128461207)
86. Tamai O, Nozato E, Miyazato H, et al. Radiation-associated rectal cancer: report of four cases. Dig Surg. 1999;16(3):238-43. (Pubitemid 29361291)
87. Nakao A, Iwagaki H, Yoshino T, et al. Immunohistochemical studies of colorectal cancers that developed following pelvic irradiation. Surg Today. 2000;30(2):117-21. (Pubitemid 30133754)
88. Yokoyama S, Takifuji K, Arii K, et al. Radiation-induced rectal cancer originating from a rectocutaneous fistula: report of a case. Surg Today. 2004;34(8):706-9. (Pubitemid 39061751)
89. Denman DL, Kirchner FR, Osborne JW. Induction of colonic adenocarcinoma in the rat by X-irradiation. Cancer Res. 1978;38(7):1899-905. (Pubitemid 8375068)
90. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.
91. Shamsuddin AK, Elias EG. Rectal mucosa. Malignant and premalignant changes after radiation therapy. Arch Pathol Lab Med. 1981;105(3):150-1. (Pubitemid 11136449)
92. Asayama N, Ikehara H, Yano H, et al. Endoscopic submucosal dissection of multiple flat adenomas in the radiated rectum. World J Gastrointest Endosc. 2013;5(3):128-31.
93. Bourguignon MH, Gisone PA, Perez MR, et al. Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging. 2005;32(2):229-46. (Pubitemid 40248495)
94. Sharp C, Cox R. Genetic susceptibility to radiation effects: possible implication for medical ionising radiation exposures. Eur J Nucl Med. 1999;26(4):425-8. (Pubitemid 29176455)
95. Nakatsuka H, Shimizu Y, Yamamoto T, et al. Colorectal cancer incidence among atomic bomb survivors, 1950-80. J Radiat Res. 1992;33(4):342-61.
96. Babior BM. Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med. 1978;298(13):721-5. (Pubitemid 8312849)
97. Valko M, Rhodes CJ, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160(1):1-40. (Pubitemid 43227479)
98. Troll W, Wiesner R. The role of oxygen radicals as a possible mechanism of tumor promotion. Annu Rev Pharmacol Toxicol. 1985;25:509-28. (Pubitemid 15090992)
99. Feinendegen LE. Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol. 2005;78(925):3-7. (Pubitemid 40277127)
100. Haton C, Francois A, Vandamme M, et al. Imbalance of the antioxidant network of mouse small intestinal mucosa after radiation exposure. Radiat Res. 2007;167(4):445-53. (Pubitemid 351292975)
101. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res. 2003;159(5):567-80. (Pubitemid 36539236)
102. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer. 2009;9(5):351-60.
103. Lyng FM, Seymour CB, Mothersill C. Production of a signal by irradiated cells which leads to a response in unirradiated cells characteristic of initiation of apoptosis. Br J Cancer. 2000;83(9):1223-30.
104. Morgan WF, Hartmann A, Limoli CL, et al. Bystander effects in radiation-induced genomic instability. Mutat Res. 2002;504(1-2):91-100. (Pubitemid 34775103)
105. Lewis DA, Mayhugh BM, Qin Y, et al. Production of delayed death and neoplastic transformation in CGL1 cells by radiation-induced bystander effects. Radiat Res. 2001;156(3):251-8. (Pubitemid 32801094)
106. Kruidenier L, Kuiper I, Van Duijn W, et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol. 2003;201(1):17-27. (Pubitemid 37121199)
107. Indaram AV, Visvalingam V, Locke M, et al. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease. Am J Gastroenterol. 2000;95(5):1221-5. (Pubitemid 30263516)
108. Stoffel E, Mukherjee B, Raymond VM, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009;137(5):1621-7.
109. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073-87 e3.
110. Jass JR, Cottier DS, Jeevaratnam P, et al. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet. 1995;346(8984):1200-1.
111. Young J, Simms LA, Biden KG, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001;159(6):2107-16. (Pubitemid 33104265)
112. Shia J, Ellis NA, Paty PB, et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol. 2003;27(11):1407-17. (Pubitemid 37315192)
113. Valle L, Perea J, Carbonell P, et al. Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol. 2007;25(7):781-6. (Pubitemid 350002877)
114. Jin HY, Liu X, Li VK, et al. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer. BMC Cancer. 2008;8:44.
115. Chiang JM, Yeh CY, Changchien CR, et al. Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups. Int J Colorectal Dis. 2010;25(8):941-7.
116. Konishi M, Kikuchi-Yanoshita R, Tanaka K, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology. 1996;111(2):307-17. (Pubitemid 26256718)
117. Leopoldo S, Lorena B, Cinzia A, et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol. 2008;15(5):1429-39.